An antibody for treating advanced prostate cancer improves progression-free survival in patients with metastasised, castration-resistant prostate cancer. This is the
Read more
Home » Immunotherapy »
A team of scientists led by a researcher at the Case Western Reserve University School of Medicine is making strides
Read more
Cancer patients responded better to immunotherapy and had a better prognosis if their melanoma tumors contained specific clusters of B
Read more
Researchers at Johns Hopkins Kimmel Cancer Center, the Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Johns Hopkins University School of
Read more
Results from the NRG Oncology phase I clinical trial NRG-GOG 9929 show that using the immunotherapy drug ipilimumab after chemoradiotherapy
Read more
Cancer immunotherapy drugs trigger the body’s immune system to attack tumors and have revolutionized the treatment of certain cancers, such
Read more
A research team led by experts at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center
Read more
Pancreatic cancer is especially challenging to treat—only eight percent of patients are still alive five years after diagnosis. Chemotherapy and
Read more
A new study led by scientists in the Center for Cancer Research (CCR) at the National Cancer Institute (NCI) sheds
Read more
(HealthDay)—Adverse events for immune checkpoint inhibitors used to treat non-small cell lung cancer (NSCLC) may be more common in real-world
Read more